Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2024-08-02 00:00:00 ET · period of report 2024-07-31 · accession 0001437749-24-024503 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-02 | 2024-07-31 | BKYI | DEPASQUALE MICHAEL W | CEO, Dir, COB | A - Grant | $0.00 | +24.0K | 44.6K | +117% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-31 | A | A | 24,000 | $0.00 | 44,573 | D | — | — | (F1) Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. (F2) Holdings do not include options to purchase 348 shares and warrants to purchase 12,667 shares. |